These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36243653)

  • 21. Asynchronous consult report generation for pharmacogenomic clinical support: Time and motion.
    Bright DR; Klepser D; Langerveld A
    Res Social Adm Pharm; 2024 Jun; 20(6):152-155. PubMed ID: 38494381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment.
    Chen C; Roberts MH; Raisch DW; Thompson TA; Bachyrycz A; Borrego ME
    Per Med; 2022 Nov; 19(6):535-548. PubMed ID: 36317592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication Optimization Using Pharmacogenomic Testing in a Complex Mental Health Population Prescribed Psychiatric Polypharmacy.
    Wood AE; Agrawal D; Deem AP; Dupper Knoper TL; Merino RF; Molzof HE; Maus LE; Kim F; Lodin Z; Lim S
    J Clin Pharmacol; 2022 Jul; 62(7):898-904. PubMed ID: 35075665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
    Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
    Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
    Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
    Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
    Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG
    Front Genet; 2021; 12():712602. PubMed ID: 34745204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
    Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
    Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
    Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of a panel-based pharmacogenomics testing program among members of a commercial and Medicare client of a pharmacy benefits manager.
    Steinbach M; Wickizer M; Siwak A; Patel T; Olson J; Horowitz S; Topp R
    J Manag Care Spec Pharm; 2022 Apr; 28(4):485-490. PubMed ID: 35332788
    [No Abstract]   [Full Text] [Related]  

  • 34. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the barriers and enablers of pharmacogenomic testing in primary care: a qualitative systematic review with meta-aggregation synthesis.
    Qureshi S; Latif A; Condon L; Akyea RK; Kai J; Qureshi N
    Pharmacogenomics; 2022 Jan; 23(2):135-154. PubMed ID: 34911350
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 38. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
    Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
    J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices.
    Luke MJ; Krupetsky N; Liu H; Korenvain C; Crown N; Toenjes S; Sproule BA; Piquette-Miller M; Guirguis LM; McCarthy LM
    Pharmacy (Basel); 2021 Dec; 9(4):. PubMed ID: 34941633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.